These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12813173)

  • 21. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
    Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
    Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
    Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
    Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
    Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
    Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
    Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
    Corcoran A; Nadkarni S; Yasuda K; Sakaki T; Brown G; Kutner A; Marcinkowska E
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26840307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies.
    Berkovich L; Sintov AC; Ben-Shabat S
    Invest New Drugs; 2013 Apr; 31(2):247-55. PubMed ID: 22661288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.
    Tan X; Li Y; Liu Y
    J Am Soc Nephrol; 2006 Dec; 17(12):3382-93. PubMed ID: 17082242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
    Br J Haematol; 2000 Jun; 109(3):576-83. PubMed ID: 10886207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
    Fujii H; Yonekura Y; Nakai K; Kono K; Goto S; Nishi S
    J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.
    Kawa S; Yoshizawa K; Tokoo M; Imai H; Oguchi H; Kiyosawa K; Homma T; Nikaido T; Furihata K
    Gastroenterology; 1996 May; 110(5):1605-13. PubMed ID: 8613068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
    Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
    Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
    Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
    Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.